Detailed View
RPRX - Royalty Pharma plc
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
35,224,850,432
Adj EBIT (TTM)
2,222,435,000
Enterprise Value
46,327,731,432
Last Price
60.96
Earnings Yield
4.80%
Return on Capital
12.17%
Capital
18,265,308,000
1Y Price Chart
Last Price: $60.96
1Y Change: 68.49%
As of 2026-10-16 | 1Y Change: 68.49%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 674,141,000 | 133,119,000 |
| 2026-03-31 | 10-Q | 2026 | 630,576,000 | 563,038,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 621,990,000 | 388,381,000 |
| 2025-09-30 | 10-Q | 2025 | 609,291,000 | 427,156,000 |
| 2025-06-30 | 10-Q | 2025 | 578,665,000 | 209,799,000 |
| 2025-03-31 | 10-Q | 2025 | 568,247,000 | 534,182,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 593,641,000 | 361,514,000 |
| 2024-09-30 | 10-Q | 2024 | 564,690,000 | 735,074,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.